Immunotherapy improves survival for patients with neuroblastoma.
McBride
Deborah
D
Kaiser Permanente Oakland Medical Center, CA, USA.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D007167:Immunotherapy; D009447:Neuroblastoma / Q000628:therapy*
D000911:Antibodies, Monoclonal; C112746:dinutuximab